Condition: Stroke · Sponsor: Universiteit Antwerpen
This is a randomized parallel group clinical trial which will be conducted in three countries (Spain, Canada and Belgium) comparing Botulinum Toxin type A (BTX-A) and Dry Needling (DN) effectiveness for post-stroke spasticity in participants who had a first stroke in the previous 12 months and have plantar flexor spasticity. Participants will be randomly allocated to receive either one session of BTX-A or 12 weekly sessions of DN. Blinded evaluators will assess the effects before, during, and after treatment, and at a 4-week follow-up.
This description comes directly from the study's public registry record.
Pablo Herrero Gallego, PhD · +34646168248 · pherrero@unizar.es
Clara Pujol Fuentes, Msc · +34661075990 · clara.pujol.fisioterapeuta@gmail.com
Always discuss trial participation with your own doctor first.
| Universiteit Antwerpen | Antwerp, Flanders, Belgium | Recruiting |
| Jewish Rehabilitation Hospital | Montreal, Quebec, Canada | Recruiting |
| Hospital Clínico Universitario Lozano Blesa | Zaragoza, Zaragoza, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06296082